Author:
Lemoine Maud,Tillmann Hans L
Reference11 articles.
1. (WHO) WHO. Towards the elimination of hepatitis B and C by 2030. 2016 http://wwwworldhepatitissummitorg/docs/default-source/default-document-library/2015/resources/towards-elimination-dr-gottfried-hirnschallpdf?sfvrsn=6 (accessed 23 Nov 2016).
2. WHO. Global hepatitis report,2017. http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1
3. Llibre A , Shimakawa Y , Mottez E , et al . Development and clinical validation of the genedrive point-of-care test for qualitative detection of hepatitis C virus. Gut 2018.doi:10.1136/gutjnl-2017-315783
4. WHO. WHO list of prequalified in vitro diagnostic products. 2017 http://www.who.int/diagnostics_laboratory/evaluations/PQ_list/en/
5. Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献